Relationship between metabolic syndrome and gallbladder stone

Korean Journal of Family Medicine

Volumn 30, Issue 8, 2009, Pages 610-616

  Kim, Jonguk ^a   Lee, Keunmi ^a  

^a Yeungnam University College of Medicine   (South Korea)

Author keywords

Body mass index; Gallbladder stone; Metabolic syndrome X; Obesity

Indexed keywords

EID: 80053601302     PISSN: 20056443     EISSN: 20926715     Source Type: Journal    
DOI: 10.4082/kjfm.2009.30.8.610     Document Type: Article

References (29)

1. Archard C, Thiers J. Le virlisme pilaire et son association al' insuffisance glycolytique (diabete des femmes a barb). Bull Acad Natl Med 1921;86:51-64.
2. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956;4:20-34.
3. Welborn TA, Breckenridge A, Rubinstein AH, Dollery CT, Fraser TR. Serum-insulin in essential hypertension and in peripheral vascular disease. Lancet 1966;1:1336-7.
4. Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
5. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-94.
6. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287:356-9.
7. Park SB. The relation of cardiovascular risk factors to metabolic syndrome. J Korean Acad Fam Med 2005;26:614-20.
8. Kim SM, Kim KM, Lee DJ. Relationship of uric acid concentration to free fat acid, cardiovascular risk factors and intraperitoneal fat. Korean J Obesity 1997;6:51-8.
9. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-9.
10. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110:1245-50.
11. Russo MW, Wei JT, Thiny MT, Gangarosa LM, Brown A, Ringel Y, et al. Digestive and liver diseases statistics, 2004. Gastroenterology 2004;126:1448-53.
12. Diehl AK. Cholelithiasis and the insulin resistance syndrome. Hepatology 2000;31:528-30.
13. The Korean Society of Gastroenterology. Gallstone disease. Seoul: Koonja Pub.; 1999.
14. Kim SJ, Lim HM, Chang IT, Lee JH, Chi KC, Cha SJ. Clinical analysis ofb iliary stone disease in Korea: 3,000 cases. J Korean Surg Soc 1991;41:325-34.
15. Kim MH, Ohrr HC, Chung JB, Kim CD, Kang JK, Koh MS, et al. The epidemiologic study on Korean gallstone disease a natiinwide cooperative study. Korean J Gastroenterol 1998;32: 635-47.
16. Mendez-Sanchez N, Chavez-Tapia NC, Uribe M. The role of dietary fats in the pathogenesis of gallstones. Front Biosci 2003;8:e420-7.
17. Mendez-Sanchez N, Chavez-Tapia NC, Motola-Kuba D, Sanchez-Lara K, Ponciano-Rodriguez G, Baptista H, et al. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol 2005;11:1653-7.
18. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III). JAMA 2001;285:2486-97.
19. Mendez-Sanchez N, Jessurun J, Ponciano-Rodriguez G, Alonsode-Ruiz P, Uribe M, Hernandez-Avila M. Prevalence of gallstone disease in Mexico: a necropsy study. Dig Dis Sci 1993;38:680-3.
20. Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 1999;84:1513-7.
21. Barbara L, Sama C, Morselli Labate AM, Taroni F, Rusticali AG, Festi D, et al. A population study on the prevalence of gallstone disease: the Sirmione study. Hepatology 1987;7:913-7.
22. Stampfer MJ, Maclure KM, Colditz GA, Manson JE, Willett WC. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr 1992;55:652-8.
23. Everhart JE. Contributions of obesity and weight loss to gallstone disease. Ann Intern Med 1993;119:1029-35.
24. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003;163:427-36.
25. Scragg RK, Calvert GD, Oliver JR. Plasma lipids and insulin in gall stone disease: a case-control study. Br Med J (Clin Res Ed) 1984;289:521-5.
26. Kajiyama G, Oyamada K, Nakao S, Miyoshi A. The effect of diabetes mellitus and its treatment on the lithogenesity of bile in man. Hiroshima J Med Sci 1981;30:221-7.
27. Brunzell JD. Obesity, diabetes and hypertriglyceridemia. In: Bjorntorp P, Cairella M, Howard AN, editors. Recent advances in obesity research. London: John Libbey: 1980. p. 239-47.
28. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes 1998;47:699-713.
29. Korea Centers for Disease Control and Prevention. Korean National Health and Nutrition Examination Survey. Seoul: Korea Centers for Disease Control and Prevention; 1998.